TP53 and cancer: Since cells infected by lentivirus may exhibit insertional mutagenesis27, which would raise safety concerns, we analyzed cancer-related TP53 mutations in three DOPA-MSC lines by RNA-seq data according to a well-established protocol28,29 and did not detect any reported mutation sites of TP53 in these DOPA-MSCs (Supplementary Fig. 3a).